MX390160B - Método de pronóstico en cáncer de mama. - Google Patents

Método de pronóstico en cáncer de mama.

Info

Publication number
MX390160B
MX390160B MX2015016721A MX2015016721A MX390160B MX 390160 B MX390160 B MX 390160B MX 2015016721 A MX2015016721 A MX 2015016721A MX 2015016721 A MX2015016721 A MX 2015016721A MX 390160 B MX390160 B MX 390160B
Authority
MX
Mexico
Prior art keywords
hsa
mir
breast cancer
prognosis
prognosis method
Prior art date
Application number
MX2015016721A
Other languages
English (en)
Other versions
MX2015016721A (es
Inventor
Ocampo Iván Uriel Bahena
Zajgla Jorge Meléndez
Original Assignee
Instituto Nac De Medicina Genomica
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instituto Nac De Medicina Genomica filed Critical Instituto Nac De Medicina Genomica
Priority to MX2015016721A priority Critical patent/MX390160B/es
Priority to PCT/MX2016/000119 priority patent/WO2017095213A1/es
Publication of MX2015016721A publication Critical patent/MX2015016721A/es
Publication of MX390160B publication Critical patent/MX390160B/es

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

La presente invención se refiere a un método in vitro útil para el pronóstico en un individuo diagnosticado con cáncer de mama, dicho método caracterizado porque comprende: (a) determinar el perfil de expresión de una firma de miRMAs asociados al fenotipo troncal de las células del cáncer de mama que comprende hsa-miR-224, hsa-miR-372, hsa-miR-10b hsa-miR548a, hsa-miR-24-1 en una muestra biológica previamente obtenida (b) comparar el nivel de expresión de dicha firma contra un perfil de expresión tipo de dichos miRNAs; y (c) calcular el pronóstico del individuo con base en el número de miRNAs de la firma que se encuentran desregulados.
MX2015016721A 2015-12-04 2015-12-04 Método de pronóstico en cáncer de mama. MX390160B (es)

Priority Applications (2)

Application Number Priority Date Filing Date Title
MX2015016721A MX390160B (es) 2015-12-04 2015-12-04 Método de pronóstico en cáncer de mama.
PCT/MX2016/000119 WO2017095213A1 (es) 2015-12-04 2016-11-23 Método de pronóstico en cáncer de mama

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2015016721A MX390160B (es) 2015-12-04 2015-12-04 Método de pronóstico en cáncer de mama.

Publications (2)

Publication Number Publication Date
MX2015016721A MX2015016721A (es) 2017-06-05
MX390160B true MX390160B (es) 2025-03-20

Family

ID=58797455

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2015016721A MX390160B (es) 2015-12-04 2015-12-04 Método de pronóstico en cáncer de mama.

Country Status (2)

Country Link
MX (1) MX390160B (es)
WO (1) WO2017095213A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN109913551A (zh) * 2019-03-26 2019-06-21 深圳大学 乳腺癌分型的核酸组合物、乳腺癌分型试剂盒及其使用方法
KR20260025789A (ko) 2023-06-22 2026-02-24 폰다치오네 디 렐리조네 에 디 쿨토 "카사 솔리에보 델라 소페렌차" - 오페라 디 산 피오 다 피에트렐치나 비전이성 여성 유방암의 예후 예측 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103820562B (zh) * 2005-08-01 2015-05-13 俄亥俄州立大学研究基金会 用于乳腺癌的诊断、预后和治疗的基于MicroRNA的方法和组合物
US8859202B2 (en) * 2012-01-20 2014-10-14 The Ohio State University Breast cancer biomarker signatures for invasiveness and prognosis

Also Published As

Publication number Publication date
MX2015016721A (es) 2017-06-05
WO2017095213A1 (es) 2017-06-08

Similar Documents

Publication Publication Date Title
MX2017007535A (es) Sistema y metodos para derivar biomarcadores de firmas geneticas de la respuesta a antagonistas de muerte programada 1 (pd-1).
GB2531881A (en) Method of isolating circulating tumor cells
MY188938A (en) Therapeutic, diagnostic and prognostic methods for cancer of the bladder
MX2019002425A (es) Micro ácidos ribonucleicos como biomarcadores para la endometriosis.
MY194686A (en) Detection of chromosome interactions
MX2016011612A (es) Determinacion de agresividad, pronostico y responsividad del cancer al tratamiento.
MY188348A (en) Single-molecule sequencing of plasma dna
MX2022015737A (es) Compuestos para mejorar el empalme del acido ribonucleico mensajero (arnm).
MY176706A (en) Biomarkers and methods of treating pd-1 and pd-l1 related conditions
MX341840B (es) Biomarcadores de microarn indicativos de la enfermedad de alzheimer.
NZ629555A (en) Monocyte biomarkers for cancer detection
BR112015032031A8 (pt) método para estimar uma fração de ácido nucleico em uma amostra de teste de uma mulher grávida
EP2673589A4 (en) TOLERANCE EVALUATION WITH LESS MEASURED POINTS
WO2013107459A3 (en) Microrna for diagnosis of pancreatic cancer and/or prognosis of patients with pancreatic cancer by blood samples
PH12013502340A1 (en) Biomarkers for hedgehog inhibitor therapy
MX2021009297A (es) Composiciones, dispositivos, y metodos de pruebas de sensibilidad del ibs.
BR112017013667A2 (pt) aparelho, sistema, e, método para determinação de afastamento.
EP3798316A3 (en) Genes and gene signatures for diagnosis and treatment of melanoma
SA517380741B1 (ar) طريقة ومعدة لتحليل جين
WO2019094780A3 (en) Non-coding rna for detection of cancer
NZ730124A (en) A method of predicting risk of recurrence of cancer
MX2022013471A (es) Metodo y composiciones de deteccion y cuantificacion de acido nucleico.
AU2016250096A8 (en) Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features
WO2014187884A3 (en) Mirnas as non-invasive biomarkers for heart failure
PH12017501957A1 (en) Herbicide-tolerant maize plant dbn9858, and nucleotide sequence and method for detecting same